Yamada et al.
JOCArticle
in Katsuura Bay, Japan, in October 2000. The fish was disin-
fected with EtOH and its gastrointestinal tract applied to the
surface of nutrient agar layered in a Petri dish. Serial transfers of
one of the resulting colonies provided a pure strain of A.
fumigatus. The fungal strain was cultured at 27 °C for 6 weeks
in a liquid medium (75 L) containing 1% soluble starch and
0.1% casein in 50% artificial seawater adjusted to pH 7.4. The
culture was filtered under suction, and the culture filtrate was
extracted three times with EtOAc. The combined extracts
were evaporated in vacuo to afford a mixture of crude metabo-
lites (18.8 g) that exhibited cytotoxicity against P388 cell line
(IC50 < 1 μg/mL). The EtOAc extract was passed through a
Sephadex LH-20 column using CHCl3-MeOH (1: 1) as the
eluent. The second fraction (14.6 g), exhibiting strong activity,
was chromatographed on a silica gel column with CHCl3-
MeOH gradient as the eluent. The 100% CHCl3 eluate (1.2 g)
was purified by ODS HPLC using MeOH-H2O (70: 30) as the
eluent to afford fraction 1 (20.3 mg) and fraction 2 (100.7 mg)
exhibiting cytotoxicity. Fraction 1 was further purified by ODS
HPLC using MeCN-H2O (45: 55) as the eluent to afford 1
(7.4 mg) and 2 (8.2 mg). Fraction 2 was further purified by ODS
HPLC using MeCN-H2O (45: 55) as the eluent to afford 4
(64.0 mg) and 3 (1.1 mg).
(rel int) 415 ([M]þ, 55.6); HRFABMS [M]þ m/z 415.1639
(C22H25NO7, calcd [M]þ 415.1631); H NMR δ ppm (CDCl3)
1
1.23 (3H, t, J=7.5 Hz, H-15), 1.98 (3H, s, H-16), 2.04 (1H, d, J=
11.8 Hz, 4-OH), 2.45 (1H, d, J=4.2 Hz, 17-OH), 2.61 (1H, d, J=
7.8 Hz, 9-OH), 2.66 (2H, q, J = 7.5 Hz, H-14), 3.35 (3H, s,
8-OCH3), 4.63 (1H, d, J=7.8 Hz, H-9), 4.87 (1H, d, J=4.2 Hz,
H-17), 5.10 (1H, d, J =11.8 Hz, H-4), 6.02 (1H, d, J =3.0 Hz,
H-12), 6.47 (1H, d, J = 3.0 Hz, H-11), 6.68 (1H, br s, H-7),
7.37-7.47 (5H, m, Ar-H).
5b: pale yellow oil; [R]22D -150.5 (c 0.09, EtOH); IR (liquid)
ν
max 3376, 2939, 1721, 1612, 1563, 1532 cm-1; UV (EtOH) λmax
(log ε) 220 (3.97), 274 (3.95), 335 (3.81) nm; FABMS m/z (rel int)
415 ([M]þ, 52.6); HRFABMS [M]þ m/z 415.1629 (C22H25NO7,
calcd [M]þ 415.1631); H NMR δ ppm (CDCl3) 1.22 (3H, t,
1
J = 7.5 Hz, H-15), 1.98 (3H, s, H-16), 2.09 (1H, d, J = 11.8
Hz, 4-OH), 2.58 (1H, br s, 17-OH), 2.65 (2H, q, J = 7.5 Hz,
H-14), 2.74 (1H, d, J = 7.6 Hz, 9-OH), 3.50 (3H, s, 8-OCH3),
4.39 (1H, d, J=7.6 Hz, H-9), 4.96 (1H, d, J=4.2 Hz, H-17), 5.15
(1H, d, J = 11.8 Hz, H-4), 5.99 (1H, d, J = 3.0 Hz, H-12), 6.40
(1H, d, J=3.0 Hz, H-11), 6.65 (1H, br s, H-7), 7.36-7.43 (5H, m,
Ar-H).
6a: pale yellow oil; [R]22 -78.4 (c 0.10, EtOH); IR (liquid)
D
max 3467, 2940, 1730, 1705, 1614, 1567, 1508 cm-1; UV (EtOH)
ν
Cephalimysin B (1): pale yellow oil; [R]22 þ129.7 (c 0.09,
λmax (log ε) 216 (4.00), 284 (3.90), 317 (3.98), 355 (3.95) nm;
FABMS m/z (rel int) 414 ([M þ H]þ, 31.1); HRFABMS [M þ
H]þ m/z 414.1561 (C22H24NO7, calcd [M þ H]þ 414.1553); 1H
NMR δ ppm (CDCl3) 1.30 (3H, d, J=7.4 Hz, H-15), 1.97 (3H, s,
H-16), 2.40 (1H, br s, 17-OH), 2.77 (2H, q, J = 7.4 Hz, H-14),
3.20 (3H, s, 8-OCH3), 3.61 (1H, d, J=11.3 Hz, 9-OH), 4.85 (1H,
br s, H-17), 4.97 (1H, d, J=11.3 Hz, H-9), 6.24 (1H, d, J=3.6
Hz, H-12), 6.60 (1H, br s, H-7), 7.09 (1H, d, J=3.6 Hz, H-11),
7.38-7.44 (3H, m, Ar-H), 7.46-7.49 (2H, m, Ar-H); 13C NMR
δ ppm (CDCl3) 6.1 (C-16), 11.8 (C-15), 21.8 (C-14), 52.6
(8-CH3), 73.4 (C-9), 74.3 (C-17), 87.5 (C-5), 91.6 (C-8), 107.7
(C-12), 108.0 (C-3), 118.0 (C-11), 127.2 (C-19, C-23), 128.7
(C-20, C-22), 129.0 (C-21), 137.8 (C-18), 143.6 (C-10), 163.5
(C-13), 167.5 (C-6), 172.3 (C-2), 196.0 (C-4).
D
EtOH); IR (liquid) νmax 3304, 2932, 1732, 1695, 1621, 1568,
1509 cm-1; UV (EtOH) λmax (log ε) 210 (3.85), 249 (3.95), 318
(3.85), 355 (3.85) nm; NMR data, see Table 1 and Table S1
(Supporting Information); FABMS m/z (rel int) 412 ([M þ H]þ,
52.2), 380 ([M - OCH3]þ, 100); HRFABMS m/z 412.1394 [M þ
H]þ (calcd for C22H22NO7 412.1397); CD (c 2.37 ꢀ 10-4 M,
EtOH) λ (Δε) 386 (0), 352 (5.5), 337 (0), 318 (-7.7), 283 (0) nm.
Cephalimysin C (2): pale yellow oil; [R]22 -209.2 (c 0.09,
D
EtOH); IR (liquid) νmax 3347, 2933, 1724, 1704, 1617, 1566, 1507
cm-1; UV (EtOH) λmax (log ε) 212 (3.79), 249 (3.88), 318 (3.79),
358 (3.76) nm; NMR data, see Table 1 and Table S2 (Supporting
Information); FABMS m/z (rel. int. %) 412 ([MþH]þ, 100), 380
([M-OCH3]þ, 13.2); HRFABMS m/z 412.1395 [MþH]þ (calcd
for C22H22NO7: 412.1397); CD (c 2.90ꢀ10-4 M, EtOH) λ (Δε)
391 (0), 346 (-12.7), 296 (0) nm.
6b: pale yellow oil; [R]22D þ145.6 (c 0.10, EtOH); IR (liquid)
ν
max 3418, 2941, 1730, 1698, 1616, 1568, 1509 cm-1; UV (EtOH)
Cephalimysin D (3): pale yellow oil; [R]22 -236.6 (c 0.11,
λmax (log ε) 215 (3.86), 284 (3.75), 312 (3.85), 357 (3.82) nm;
D
FABMS m/z (rel int) 414 ([M þ H]þ, 17.9); HRFABMS [M þ
EtOH); IR (liquid) νmax 3289, 2937, 1732, 1691, 1612, 1563,
1507 cm-1; UV (EtOH) λmax (log ε) 210 (3.85), 248 (3.95), 315
(3.87), 356 (3.83) nm; NMR data, see Table 1 and Table S3
(Supporting Information); FABMS m/z (rel int) 412 ([M þ H]þ,
100), 380 ([M - OCH3]þ, 44.2); HRFABMS m/z 412.1399 [M þ
H]þ (calcd for C22H22NO7 412.1397); CD (c 2.55 ꢀ 10-4 M,
EtOH) λ (Δε) 389 (0), 344 (-10.2), 293 (0) nm.
1
H]þ m/z 414.1554 (C22H24NO7, calcd [M þ H]þ 414.1553); H
NMR δ ppm (CDCl3) 1.27 (3H, d, J=7.7 Hz, H-15), 1.95 (3H, s,
H-16), 2.73 (2H, q, J=7.7 Hz, H-14), 2.93 (1H, br s, 17-OH), 3.52
(1H, d, J=11.0 Hz, 9-OH), 3.58 (3H, s, 8-OCH3), 4.64 (1H, d, J=
11.0 Hz, H-9), 4.89 (1H, br s, H-17), 6.20 (1H, d, J = 3.6 Hz,
H-12), 7.01 (1H, d, J=3.6 Hz, H-11), 7.05 (1H, br s, H-7), 7.36 -
7.42 (5H, m, Ar-H); 13C NMR δ ppm (CDCl3) 6.1 (C-16), 11.7
(C-15), 21.7 (C-14), 52.8 (8-CH3), 73.8 (C-9), 75.9 (C-17), 88.0
(C-5), 91.5 (C-8), 107.6 (C-12), 108.0 (C-3), 118.0 (C-11), 127.2
(C-19, C-23), 128.5 (C-20, C-22), 128.8(C-21), 137.6 (C-18), 143.5
(C-10), 163.6 (C-13), 168.1 (C-6), 172.2 (C-2), 195.8 (C-4).
FD-838 (4): pale yellow oil; [R]22D þ40.5 (c 0.10, EtOH); IR
(liquid) νmax 3433, 2921, 1734, 1681, 1619, 1566, 1506 cm-1; UV
(EtOH) λmax (log ε) 210 (3.82), 252 (3.92), 319 (3.86), 356
(3.83) nm; NMR data, see Table 1; FABMS m/z (rel int) 412
([M þ H]þ, 100), 380 ([M - OCH3]þ, 32.5); HRFABMS m/z
412.1398 [M þ H]þ (calcd for C22H22NO7 412.1397); CD
(c 2.47 ꢀ 10-4 M, EtOH) λ (Δε) 385 (0), 352 (3.7), 343 (0), 320
(-10.1), 290 (0) nm.
7: pale yellow oil; [R]22 þ52.9 (c 0.11, EtOH); IR (liquid)
D
max 3348, 2939, 1729, 1698, 1625, 1569, 1509 cm-1; UV (EtOH)
ν
λmax (log ε) 212 (3.92), 284 (3.79), 316 (3.93), 358 (3.91) nm;
FABMS m/z (rel int) 414 ([M þ H]þ, 100); HRFABMS [M þ
H]þ m/z 414.1554 (C22H24NO7, calcd [M þ H]þ 414.1553); 1H
NMR δ ppm (CDCl3) 1.31 (3H, d, J=7.6 Hz, H-15), 2.05 (3H, s,
H-16), 2.78 (2H, q, J = 7.6 Hz, H-14), 3.35 (1H, br s, 17-OH),
3.37 (3H, s, 8-OCH3), 4.52 (1H, br s, 9-OH), 5.02 (1H, s, H-9),
5.44 (1H, br s, H-7), 5.90 (1H, br s, H-17), 6.26 (1H, d, J =
3.7 Hz, H-12), 7.11 (1H, d, J=3.7 Hz, H-11), 7.35-7.40 (3H, m,
Ar-H), 7.52-7.44 (2H, m, Ar-H); 13C NMR δ ppm (CDCl3) 6.2
(C-16), 11.8 (C-15), 21.8 (C-14), 49.3 (8-CH3), 74.7 (C-9), 76.1
(C-17), 89.7 (C-5), 91.2 (C-8), 107.8 (C-12), 108.1 (C-3), 118.3
(C-11), 128.3 (C-19, C-23), 128.5 (C-20, C-21, C-22), 137.0
(C-18), 143.3 (C-10), 163.8 (C-13), 165.4 (C-6), 172.2 (C-2),
196.4 (C-4).
Reduction of FD-838 (4) to 5-7. NaBH4 (4.0 mg) was added to
a MeOH solution (1.5 mL) of FD-838 (4) (41.2 mg, 0.1 mmol),
and the reaction mixture was stirred at room temperature for 30
min. The mixture was diluted with water and extracted with
CHCl3, and the CHCl3 was evaporated under reduced pressure.
The residue was purified by HPLC using MeCN-H2O (45: 55)
as the eluent to afford fraction 1 (20.5 mg) and 6 (6a: 6.3 mg
and 6b: 10.2 mg). Fraction 1 was purified by HPLC using
MeCN-H2O (35: 65) as the eluent to afford 5 (5a: 5.1 mg and
5b: 3.3 mg) and 7 (3.8 mg).
5a: pale yellow oil; [R]22D -158.6 (c 0.10, EtOH); IR (liquid)
ν
λ
max 3433, 2938, 1721, 1614, 1619, 1530, 1508 cm-1; UV (EtOH)
max (log ε) 216 (3.96), 274 (3.97), 334 (3.71) nm; FABMS m/z
4152 J. Org. Chem. Vol. 75, No. 12, 2010